Artificial intelligence-enabled electrocardiography from scientific research to clinical application
- PMID: 41326714
- DOI: 10.1038/s44321-025-00351-y
Artificial intelligence-enabled electrocardiography from scientific research to clinical application
Abstract
Recent advancements in artificial intelligence (AI) have revolutionized the application of electrocardiography (ECG) in cardiovascular diagnostics. This review highlights the transformative impact of AI on traditional ECG analysis, detailing how deep learning algorithms are overcoming the limitations of human interpretation and conventional diagnostic criteria. Historically, ECG interpretation has relied on well-established, physiologically-based criteria. The advancement of AI-ECG is marked by its capacity to process complex high-dimensional data directly from raw signals, revealing patterns often missed by conventional methods. Notably, AI models have identified signs of asymptomatic low ejection fraction and paroxysmal atrial fibrillation during normal sinus rhythm, enabling earlier clinical intervention. In addition to improved diagnostic utility, AI-ECG offers promising applications in risk stratification and community screening. Several randomized controlled trials (RCTs) have shown that integrating AI into clinical workflows not only reduces critical intervention times but also identifies patients at elevated risk of adverse outcomes. Future directions involve integrating additional clinical data sources, improving model interpretability through explainable AI, and developing unified platforms to manage outputs from multiple models.
Keywords: Artificial Intelligence; Digital Biomarker; Electrocardiography; Opportunistic Screening; Paradigm Shift.
© 2025. The Author(s).
Conflict of interest statement
Disclosure and competing interests statement. The authors declare no competing interests.
References
-
- Adedinsewo D, Morales-Lara AC, Hardway H, Johnson P, Young KA, Garzon-Siatoya WT, Butler Tobah YS, Rose CH, Burnette D, Seccombe K et al (2024a) Artificial intelligence-based screening for cardiomyopathy in an obstetric population: A pilot study. Cardiovasc Digit Health J 5:132–140 - PubMed - PMC - DOI
-
- Adedinsewo DA, Morales-Lara AC, Afolabi BB, Kushimo OA, Mbakwem AC, Ibiyemi KF, Ogunmodede JA, Raji HO, Ringim SH, Habib AA et al (2024b) Artificial intelligence guided screening for cardiomyopathies in an obstetric population: a pragmatic randomized clinical trial. Nat Med 30:2897–2906 - PubMed - PMC - DOI
-
- Armoundas AA, Narayan SM, Arnett DK, Spector-Bagdady K, Bennett DA, Celi LA, Friedman PA, Gollob MH, Hall JL, Kwitek AE et al (2024) Use of artificial intelligence in improving outcomes in heart disease: a scientific statement from the American Heart Association. Circulation 149:e1028–e1050 - PubMed - PMC - DOI
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
